文献速递免疫规划

脐带血中的腮腺炎抗体:与母亲腮腺炎回忆的关联及其对疫苗接种策略的可能影响

Mumps antibodies in the cord blood: Association with maternal recall of mumps. Possible consequences for vaccination strategies.
PubMed 文献 · Vaccine · 2019-11-22

本研究检测了198份脐带血清中的抗腮腺炎IgG(MuIgG)水平及 seropositive 新生儿比例,并分析其与母亲腮腺炎回忆等变量的关联。MuIgG几何平均浓度为31.7 RU/ml,75.3%的血清为 seropositive(≥16 RU/ml)。母亲回忆曾患腮腺炎可预测更高的MuIgG GMC和 seropositivity,而母亲年龄和疫苗接种状态与GMC或 seropositivity 无关。

要点

  • 脐带血清MuIgG几何平均浓度为31.7 RU/ml,75.3%为 seropositive(≥16 RU/ml)。
  • 母亲回忆曾患腮腺炎可预测更高的MuIgG GMC和 seropositivity。
  • 母亲年龄和疫苗接种状态与GMC或 seropositivity 无关。

核心结论

  • 母亲对腮腺炎的回忆高度预测 seropositivity,而未回忆该病会导致大量假阴性。
  • 作者同意需要进一步研究以支持三剂(或更多剂)MMR策略的建议,但也认为支持更高剂量策略的证据正在快速积累。
  • 当疫苗接种成功控制(并在全国消除)麻疹和腮腺炎等目标疾病时,疫苗导致的免疫力减弱问题必须紧急加以考虑。

研究设计与样本

  • 研究数据来自198份脐带血清,所有母亲均有详细的疫苗接种记录。
  • 使用商业免疫测定法检测血清中的MuIgG。

主要发现

  • MuIgG几何平均浓度(GMC)为31.7 RU/ml。
  • Seropositive/immune sera(浓度≥16 RU/ml)占75.3%。
  • 49名母亲对是否曾患腮腺炎表示「不确定」,46名称曾患该病,103名称未患过。
  • 88名女性未接种任何剂次MMR,其余接种了1或2剂,含不同疫苗株组合。
  • 母亲回忆曾患腮腺炎可预测更高的MuIgG GMC和 seropositivity;母亲年龄和疫苗接种状态与GMC或 seropositivity 无关。

局限性

  • 作者同意需要进一步研究以支持三剂(或更多剂)MMR策略的建议。
  • 当疫苗接种成功控制(并在全国消除)麻疹和腮腺炎等目标疾病时,疫苗导致的免疫力减弱问题必须紧急加以考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The present study aims to contribute to the evaluation of the serological impact of vaccination against mumps in Portugal, measuring anti-mumps IgG (MuIgG) levels in cord sera and the corresponding proportions of seropositive newborns, and their association with potential predictive variables. The data from this study came from 198 umbilical cord sera. Detailed vaccination records were available for all mothers. MuIgG were measured in the sera, using a commercial immunoassay. The geometric mean concentration (GMC) of MuIgG was 31.7 RU/ml. Seropositive/immune sera (concentration ≥16 RU/ml) were 75.3%. While 49 mothers were "unsure" about ever having had mumps, 46 said they had had the disease and 103 said they had not had it. Eighty eight women did not receive a single dose of MMR while the other received 1 or 2 doses, with different combinations of vaccine strains. This study found that recalling mumps was predictive of higher MuIgG GMC and seropositivity. Maternal age and vaccination status were not associated with GMC or seropositivity. Nevertheless, in the small subset of newborns from vaccinated mothers not recalling mumps, receiving two doses was predictive of higher GMC than just receiving one. Maternal recall of mumps is highly predictive of seropositivity while not recalling the disease results in numerous false-negatives. This is consistent with other studies and with the fact that infection with mumps virus can result in a wide range of clinical manifestations. We agree on the need for further research to support a recommendation of a three (or more)-dose MMR strategy but we also believe that evidence is fast accumulating in favour of a higher dose strategy. The issue of waning immunity due to vaccines when vaccination succeeds in controlling (and nationally eliminating) target diseases like measles and mumps must be urgently taken into account.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Frade J, Nunes C, Mesquita JR, et al. Mumps antibodies in the cord blood: Association with maternal recall of mumps. Possible consequences for vaccination strategies. Vaccine. 2019. PMID: 31767464. doi:10.1016/j.vaccine.2019.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。